AAAAAA

   
Results: 1-10 |
Results: 10
'Troy-bodies': antibodies as vector proteins for T cell epitopes
Authors: Lunde, E Rasmussen, IB Eidem, JK Gregers, TF Western, KH Bogen, B Sandlie, I
Citation: E. Lunde et al., 'Troy-bodies': antibodies as vector proteins for T cell epitopes, BIOMOL ENG, 18(3), 2001, pp. 109-116
The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: Implications for peptide vaccination
Authors: Rasmussen, IB Lunde, E Michaelsen, TE Bogen, B Sandlie, I
Citation: Ib. Rasmussen et al., The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: Implications for peptide vaccination, P NAS US, 98(18), 2001, pp. 10296-10301
T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: Critical role for asparagine deamidation
Authors: McAdam, SN Fleckenstein, B Rasmussen, IB Schmid, DG Sandlie, I Bogen, B Viner, NJ Sollid, LM
Citation: Sn. Mcadam et al., T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: Critical role for asparagine deamidation, J EXP MED, 193(11), 2001, pp. 1239-1246
Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a single cell level
Authors: Dembic, Z Rottingen, JA Dellacasagrande, J Schenck, K Bogen, B
Citation: Z. Dembic et al., Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a single cell level, BLOOD, 97(9), 2001, pp. 2808-2814
Deletion of idiotype (Id)-specific T cells in multiple myeloma
Authors: Bogen, B Schenck, K Munthe, LA Dembic, Z
Citation: B. Bogen et al., Deletion of idiotype (Id)-specific T cells in multiple myeloma, ACTA ONCOL, 39(7), 2000, pp. 783-788
Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4(+) T cells
Authors: Dembic, Z Schenck, K Bogen, B
Citation: Z. Dembic et al., Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4(+) T cells, P NAS US, 97(6), 2000, pp. 2697-2702
Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation
Authors: Eidem, JK Rasmussen, IB Lunde, E Gregers, TF Rees, AR Bogen, B Sandlie, I
Citation: Jk. Eidem et al., Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation, J IMMUNOL M, 245(1-2), 2000, pp. 119-131
Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells
Authors: Lunde, E Munthe, LA Vabo, A Sandlie, I Bogen, B
Citation: E. Lunde et al., Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells, NAT BIOTECH, 17(7), 1999, pp. 670-675
The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
Authors: Djerbi, M Screpanti, V Catrina, AI Bogen, B Biberfeld, P Grandien, A
Citation: M. Djerbi et al., The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors, J EXP MED, 190(7), 1999, pp. 1025-1031
Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo
Authors: Munthe, LA Kyte, JA Bogen, B
Citation: La. Munthe et al., Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo, EUR J IMMUN, 29(12), 1999, pp. 4043-4052
Risultati: 1-10 |